Most vaccines work by inducing an immune response characterized by neutralizing antibodies against the respective pathogen. An effective HIV vaccine has remained elusive so far, but researchers have continued to make progress, often employing innovative methods. A new study reports that a combin... Read More
A team of researchers led by Harvard geneticist George Church at the Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) has made big strides toward a future in which the predominant chemical factories of the world are colonies of genetically engineered bacteria... Read More
Microbes: They're everywhere, including inside our bodies. But are they really necessary? Not to life, scientists argue in a new paper — but certainly to life as we know it.
For starters, microbiologists Jack Gilbert and Josh Neufeld had to put aside the internal cell structures that were pro... Read More
A new study by a team of researchers that includes University of Notre Dame scientists Joshua Shrout and Mark Alber provides new insights into the behavior of an important bacterial pathogen.
Alber, Vincent J. Duncan Family Professor of Applied Mathematics, and Schrout, an associate professor... Read More
Multiple governments and non-governmental organizations have called on health-care personnel the world over to help control West Africa's Ebola outbreak; these include Médecins Sans Frontières (MSF), the World Health Organization (WHO) and United Nations children's charity UNICEF. But the demand... Read More
Bacteria that can swim propel themselves with corkscrew tails anchored in rotary motors. That may seem surprisingly mechanical for a microbe, but it is a system that has been wildly popular and conserved across billions of years of evolution.
To see what I mean, I encourage you to visit this ... Read More
Two experimental DNA vaccines to prevent Ebola virus and the closely related Marburg virus are safe, and generated a similar immune response in healthy Ugandan adults as reported in healthy US adults earlier this year. The findings are from the first trial of filovirus vaccines in Africa. Read More